Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/9677| Title: | Stroke: prediction, prevention, and outcome. | Austin Authors: | Donnan, Geoffrey A | Affiliation: | National Stroke Research Institute, Austin & Repatriation Medical Centre, University of Melbourne, Heidelberg West, Victoria, Australia | Issue Date: | 1-Jan-2004 | Publication information: | The Lancet. Neurology; 3(1): 9 | Gov't Doc #: | 14693098 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/9677 | Journal: | The Lancet. Neurology | URL: | https://pubmed.ncbi.nlm.nih.gov/14693098 | Type: | Journal Article | Subjects: | 3',5'-Cyclic-AMP Phosphodiesterases.genetics Antihypertensive Agents.therapeutic use Blood Pressure.drug effects Clinical Trials as Topic Cyclic Nucleotide Phosphodiesterases, Type 4 Fibrinolytic Agents.adverse effects.therapeutic use Humans Risk Factors Stroke.genetics.mortality.prevention & control Treatment Outcome |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.